Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort

Loreta A Kondili; Federica Romano; Francesca Romana Rolli; Matteo Ruggeri; Stefano Rosato; Maurizia Rossana Brunetto; Anna Linda Zignego; Alessia Ciancio; Alfredo Di Leo; Giovanni Raimondo; Carlo Ferrari; Gloria Taliani; Guglielmo Borgia; Teresa Antonia Santantonio; Pierluigi Blanc; Giovanni Battista Gaeta; Antonio Gasbarrini; Luchino Chessa; Elke Maria Erne; Erica Villa; Donatella Ieluzzi; Francesco Paolo Russo; Pietro Andreone; Maria Vinci; Carmine Coppola; Liliana Chemello; Salvatore Madonia; Gabriella Verucchi; Marcello Persico; Massimo Zuin; Massimo Puoti; Alfredo Alberti; Gerardo Nardone; Marco Massari; Giuseppe Montalto; Giuseppe Foti; Maria Grazia Rumi; Maria Giovanna Quaranta; Americo Cicchetti; Antonio Craxì; Stefano Vella

doi:10.1002/hep.29399

Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort

Loreta A Kondili^*
, Federica Romano
, Francesca Romana Rolli
, Matteo Ruggeri
, Stefano Rosato
, Maurizia Rossana Brunetto
, Anna Linda Zignego
, Alessia Ciancio
, Alfredo Di Leo
, Giovanni Raimondo
, Carlo Ferrari
, Gloria Taliani
, Guglielmo Borgia
, Teresa Antonia Santantonio
, Pierluigi Blanc
, Giovanni Battista Gaeta
, Antonio Gasbarrini
, Luchino Chessa
, Elke Maria Erne
, Erica Villa

Donatella Ieluzzi, Francesco Paolo Russo, Pietro Andreone, Maria Vinci, Carmine Coppola, Liliana Chemello, Salvatore Madonia, Gabriella Verucchi, Marcello Persico, Massimo Zuin, Massimo Puoti, Alfredo Alberti, Gerardo Nardone, Marco Massari, Giuseppe Montalto, Giuseppe Foti, Maria Grazia Rumi, Maria Giovanna Quaranta, Americo Cicchetti, Antonio Craxì, Stefano Vella

^*Corresponding author

Istituto Superiore di Sanita
University of Pisa
University of Florence
University of Turin
University of Bari
University of Messina
Azienda Ospedaliero - Universitaria di Parma
University of Rome La Sapienza
University of Naples Federico II
University of Foggia
Azienda Sanitaria di Firenze
University of Campania Luigi Vanvitelli
University of Cagliari
University of Padua
University of Modena and Reggio Emilia
Ospedale Policlinico
University of Bologna
Asst Grande Ospedale Metropolitano Niguarda
Gragnano Hospital
Ospedale V. Cervello
University of Salerno
University of Milan
Azienda Ospedaliera Santa Maria Nuova di Reggio Emilia
University of Palermo
Azienda Ospedaliera Bianchi-Melacrino-Morelli

Research output: Contribution to journal › Article

18 Citations (Scopus)

Abstract

n.a.

Original language	English
Pages (from-to)	N/A-N/A
Journal	Hepatology
Issue number	n/a
DOIs	https://doi.org/10.1002/hep.29399
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hepatology

Keywords

HCV
Hepatitis C
antiviral therapy
cost-effectiveness
real-life cohort

Access to Document

10.1002/hep.29399

Cite this

Kondili, L. A., Romano, F., Rolli, F. R., Ruggeri, M., Rosato, S., Brunetto, M. R., Zignego, A. L., Ciancio, A., Di Leo, A., Raimondo, G., Ferrari, C., Taliani, G., Borgia, G., Santantonio, T. A., Blanc, P., Gaeta, G. B., Gasbarrini, A., Chessa, L., Erne, E. M., ... Vella, S. (2017). Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort. Hepatology, (n/a), N/A-N/A. https://doi.org/10.1002/hep.29399

@article{062db2ab5ef64533801e30aca72e63be,

title = "Modelling cost-effectiveness and health gains of a {"}universal{"} vs. {"}prioritized{"} HCV treatment policy in a real-life cohort",

abstract = "n.a.",

keywords = "HCV, Hepatitis C, antiviral therapy, cost-effectiveness, real-life cohort, HCV, Hepatitis C, antiviral therapy, cost-effectiveness, real-life cohort",

author = "Kondili, \{Loreta A\} and Federica Romano and Rolli, \{Francesca Romana\} and Matteo Ruggeri and Stefano Rosato and Brunetto, \{Maurizia Rossana\} and Zignego, \{Anna Linda\} and Alessia Ciancio and \{Di Leo\}, Alfredo and Giovanni Raimondo and Carlo Ferrari and Gloria Taliani and Guglielmo Borgia and Santantonio, \{Teresa Antonia\} and Pierluigi Blanc and Gaeta, \{Giovanni Battista\} and Antonio Gasbarrini and Luchino Chessa and Erne, \{Elke Maria\} and Erica Villa and Donatella Ieluzzi and Russo, \{Francesco Paolo\} and Pietro Andreone and Maria Vinci and Carmine Coppola and Liliana Chemello and Salvatore Madonia and Gabriella Verucchi and Marcello Persico and Massimo Zuin and Massimo Puoti and Alfredo Alberti and Gerardo Nardone and Marco Massari and Giuseppe Montalto and Giuseppe Foti and Rumi, \{Maria Grazia\} and Quaranta, \{Maria Giovanna\} and Americo Cicchetti and Antonio Crax{\`i} and Stefano Vella",

year = "2017",

doi = "10.1002/hep.29399",

language = "English",

pages = "N/A--N/A",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

number = "n/a",

}

Kondili, LA, Romano, F, Rolli, FR, Ruggeri, M, Rosato, S, Brunetto, MR, Zignego, AL, Ciancio, A, Di Leo, A, Raimondo, G, Ferrari, C, Taliani, G, Borgia, G, Santantonio, TA, Blanc, P, Gaeta, GB, Gasbarrini, A, Chessa, L, Erne, EM, Villa, E, Ieluzzi, D, Russo, FP, Andreone, P, Vinci, M, Coppola, C, Chemello, L, Madonia, S, Verucchi, G, Persico, M, Zuin, M, Puoti, M, Alberti, A, Nardone, G, Massari, M, Montalto, G, Foti, G, Rumi, MG, Quaranta, MG, Cicchetti, A, Craxì, A & Vella, S 2017, 'Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort', Hepatology, no. n/a, pp. N/A-N/A. https://doi.org/10.1002/hep.29399

TY - JOUR

T1 - Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort

AU - Kondili, Loreta A

AU - Romano, Federica

AU - Rolli, Francesca Romana

AU - Ruggeri, Matteo

AU - Rosato, Stefano

AU - Brunetto, Maurizia Rossana

AU - Zignego, Anna Linda

AU - Ciancio, Alessia

AU - Di Leo, Alfredo

AU - Raimondo, Giovanni

AU - Ferrari, Carlo

AU - Taliani, Gloria

AU - Borgia, Guglielmo

AU - Santantonio, Teresa Antonia

AU - Blanc, Pierluigi

AU - Gaeta, Giovanni Battista

AU - Gasbarrini, Antonio

AU - Chessa, Luchino

AU - Erne, Elke Maria

AU - Villa, Erica

AU - Ieluzzi, Donatella

AU - Russo, Francesco Paolo

AU - Andreone, Pietro

AU - Vinci, Maria

AU - Coppola, Carmine

AU - Chemello, Liliana

AU - Madonia, Salvatore

AU - Verucchi, Gabriella

AU - Persico, Marcello

AU - Zuin, Massimo

AU - Puoti, Massimo

AU - Alberti, Alfredo

AU - Nardone, Gerardo

AU - Massari, Marco

AU - Montalto, Giuseppe

AU - Foti, Giuseppe

AU - Rumi, Maria Grazia

AU - Quaranta, Maria Giovanna

AU - Cicchetti, Americo

AU - Craxì, Antonio

AU - Vella, Stefano

PY - 2017

Y1 - 2017

N2 - n.a.

AB - n.a.

KW - HCV

KW - Hepatitis C

KW - antiviral therapy

KW - cost-effectiveness

KW - real-life cohort

KW - HCV

KW - Hepatitis C

KW - antiviral therapy

KW - cost-effectiveness

KW - real-life cohort

UR - https://publicatt.unicatt.it/handle/10807/104764

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85033227727&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85033227727&origin=inward

U2 - 10.1002/hep.29399

DO - 10.1002/hep.29399

M3 - Article

SN - 0270-9139

SP - N/A-N/A

JO - Hepatology

JF - Hepatology

IS - n/a

ER -

Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Fingerprint

Cite this